Can a phone app help older cancer patients get moving?
NCT ID NCT04035499
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether a mobile exercise app (GO-EXCAP) is feasible for older patients (60+) with myeloid neoplasms who are receiving chemotherapy. 25 participants used the app for 7 weeks. The goal was to see if patients would actually use the app and stick with the program, not to measure health benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GO-EXCAP Mobile App (exercise program)
What this could lead to
If this works, it could show that a simple mobile exercise program is a practical way to help older blood cancer patients stay active during treatment.
What could go wrong
This is a very small pilot study with only 25 people, so results may not apply to everyone. It only tests if the program is doable, not if it actually improves health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Rochester Medical Center
Rochester, New York, 14642, United States